Skip to main content
Catalyst Healthcare PartnersHealthTech Investment

For founders

Bring us the clinical problem, not just the technology.

We are building CHP to work alongside founders on the questions that decide whether a health technology reaches everyday care: clinical need, evidence, workflow, adoption and a sustainable commercial model.

Submit an opportunity
A clinician using a handheld point-of-care imaging device at the bedside

What we intend to bring

Capability alongside capital.

These are the areas our operating model is being built around. They describe intended support, not a guaranteed service.

  • 01

    Clinical validation

    Physician-led assessment, governed pilots and outcome measurement in real care settings.

  • 02

    Workflow and adoption

    Nursing and operational review of usability, integration and training needs.

  • 03

    Regional market entry

    Regulatory, reimbursement and partnership pathways across international markets.

  • 04

    Staged capital

    Investment aligned to evidence and milestones rather than a single upfront decision.

What we look for

Signals of fit.

  • A defined healthcare problem and a credible technical solution.
  • A team able to work with clinicians and healthcare organisations.
  • A willingness to generate evidence for the intended use.
  • Relevance to a care setting in our areas of investment interest.

These are indicative considerations rather than formal eligibility criteria, and they do not commit CHP to review, feedback or investment.

How an opportunity is assessed

A staged process, with decision points.

  1. 01IdentifySource innovation globally and screen technologies, devices and platforms against healthcare needs and strategic fit.
  2. 02EvaluateBring together clinical expert review, scientific assessment and market attractiveness.
  3. 03ValidateUse appropriately governed clinical pilots, workflow assessment and outcome measurement to build evidence.
  4. 04ImplementAssess live integration, adoption and economic viability in relevant care settings.
  5. 05CommercialiseDevelop routes to regional deployment, licensing and strategic partnerships.

Progress at any stage depends on what the evidence shows. An opportunity may be adapted or may not continue.

Submit an opportunity

Share a non-confidential overview.

Your enquiry is pre-set to the precision medicine theme. You can change it below.

Please share a non-confidential overview only. Do not include patient information, personal health data, trade secrets or other sensitive material. Submitting this form does not create a confidentiality, advisory or investment relationship.

Descriptive only — stages are not eligibility criteria.

A brief non-confidential description is enough at this stage.